Edition:
Deutschland

Daiichi Sankyo Co Ltd (4568.T)

4568.T on Tokyo Stock Exchange

8,621JPY
3 Jul 2020
Change (% chg)

-- (--)
Prev Close
¥8,621
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,880,226
52-wk High
¥10,085
52-wk Low
¥5,193

About

DAIICHI SANKYO COMPANY, LIMITED is a Japan-based holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the... (more)

Buy/Sell

Sell Hold Buy
2.14 Mean rating from 14 analysts

Overall

Beta: 0.95
Market Cap(Mil.): ¥6,112,387.00
Shares Outstanding(Mil.): 709.01
Dividend: 40.50
Yield (%): 0.81

UPDATE 2-Daiichi Sankyo in talks with AstraZeneca on virus vaccine supply in Japan

TOKYO, June 26 Daiichi Sankyo Co is in discussions to provide supplies of a potential coronavirus vaccine now being developed by AstraZeneca Plc and the University of Oxford for use in Japan.

UPDATE 1-UK Stocks-Factors to watch on June 26

(Adds futures, news items) Britain's FTSE 100 index is seen opening 81 points higher at 6,228 on Friday, according to financial bookmakers, with futures up 0.68% ahead of cash marktes open.

Daiichi Sankyo in talks with AstraZeneca on virus vaccine supply in Japan

TOKYO, June 26 Daiichi Sankyo Co is in discussions with AstraZeneca Plc on developing supplies of a vaccine for the coronavirus in Japan, the Japanese company said on Friday.

BRIEF-Thermo Fisher, Daiichi Sankyo To Co-Develop Global Companion Diagnostic For Non-Small Cell Lung Cancer

* THERMO FISHER SCIENTIFIC AND DAIICHI SANKYO TO CO-DEVELOP GLOBAL COMPANION DIAGNOSTIC FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER

BRIEF-Esperion And Daiichi Sankyo Europe Announce Amendment To License And Commercial Collaboration Agreement

* ESPERION AND DAIICHI SANKYO EUROPE ANNOUNCE AMENDMENT TO LICENSE AND COMMERCIAL COLLABORATION AGREEMENT

Photo

Japan's AnGes speeds towards 2021 rollout in coronavirus 'vaccine war'

OSAKA Japanese biotech AnGes Inc expects its coronavirus vaccine to be ready as early as the first half of 2021, if it can overcome supply chain and production hurdles, the company's founder said.

Japan's AnGes speeds towards 2021 rollout in coronavirus 'vaccine war'

OSAKA, June 10 Japanese biotech AnGes Inc expects its coronavirus vaccine to be ready as early as the first half of 2021, if it can overcome supply chain and production hurdles, the company's founder said.

Japan stocks hit highest in more than 3 months on economic hopes

TOKYO, June 2 Japanese shares hit a more than three-month high on Tuesday as hopes for a global economic recovery bolstered expectations for a rebound in corporate earnings, with more countries gradually reopening after coronavirus-related lockdowns.

Japan shares hit over 3-month high on hopes of economic recovery boosting corporate results

TOKYO, June 2 Japanese shares hit a more than three-month high on Tuesday, as hopes for global economic recovery with more countries gradually reopening after coronavirus-related lockdowns bolstered expectations for corporate earnings.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.12%
Rohstoffe +0.08%
Industrie -0.08%
Konjunktur abhängige Waren & Dienstleistungen -0.23%
Konjunktur unabhängige Waren & Dienstleistungen -0.10%
Finanzindustrie -0.03%
Pharma +0.06%
Technologie +0.22%
Telekommunikation -0.11%